Viewing Study NCT03045393

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:05 AM
Ignite Modification Date: 2026-02-25 @ 9:30 PM
Study NCT ID: NCT03045393
Status: WITHDRAWN
Last Update Posted: 2018-07-05
First Post: 2017-02-03
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Mirvetuximab Soravtansine (IMG853) in Folate Receptor Alpha-expressing TNBC
Sponsor: Duke University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer Triple Negative View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Neoadjuvant View
None Breast Cancer View
None Folate Receptor Alpha View
None FRa View
None TNBC View
None Triple Negative Breast Cancer View
None Preoperative View
None Presurgery View
None Mirvetuximab Soravtansine View
None IMGN853 View